/Companies

CinCor Pharma

Cincinnati, US · Founded 2018 · Delaware corporation · 5 known investors

Find your way into CinCor Pharma

Sign up to find every way you can get introduced to CinCor Pharma

  • Your email: who you already know at CinCor Pharma, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the CinCor Pharma team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Advancing clinical candidates for cardiovascular, metabolic and kidney diseases. (NASDAQ: CINC) (Acquired by AstraZeneca)

Founders & leadership

MDMarc de Garidel
Marc de GaridelExecutive

Investors · 5

Funding

SEC filings, press & company announcements

$142.9M disclosed across 1 of 2 rounds · 2019–2021

▶$142.9MraisedOct 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc de GaridelExecutive Officer, Director
Offering amount
$142.9M
Amount sold
$142.9M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does CinCor Pharma do?
Advancing clinical candidates for cardiovascular, metabolic and kidney diseases. (NASDAQ: CINC) (Acquired by AstraZeneca)
Who are CinCor Pharma's investors?
CinCor Pharma's investors include Sofinnova Partners, Sofinnova Ventures, 5AM Ventures, General Atlantic, Westlake Village BioPartners.
How much funding has CinCor Pharma raised?
CinCor Pharma has disclosed $142.9M raised across 1 of its 2 known rounds.
Where is CinCor Pharma headquartered?
CinCor Pharma is headquartered in Cincinnati, US.